OTC:CASIF | Income Statement | CASI Pharmaceuticals, Inc.

Complete source-backed income-statement history.

Available history
2020-12-31 to 2025-12-31
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$20.71M$10.64M$10.08M$6.31M-$45.01M-$45.87M-$48.06M-$2.59-$2.5918,538,04618,538,046
2024-12-31$28.54M$17.39M$11.15M$8.92M-$39.62M-$38.07M$0.00-$39.26M-$2.56-$2.5615,340,27715,340,277
2023-12-31$33.88M$13.83M$20.05M$9.86M-$25.08M-$26.29M-$81,000.00-$26.96M-$2.02-$2.0213,360,18513,360,185
2022-12-31$38.05M$15.83M$27.28M$16M-$34.03M-$37.43M$1.98M-$41.01M-$3.01-$3.0113,647,45513,647,455
2021-12-31$30.02M$12.56M$17.61M-$41.52M-$35.84M$0.00-$36.65M-$2.69-$2.6913,610,44113,610,441
2020-12-31$15M$9.51M$5.63M-$52.78M-$47.51M$0.00-$48.29M-$4.37-$4.3711,045,11911,045,119